期刊文献+

胃癌患者组织环氧化酶2及血管内皮细胞增殖标志物表达的变化研究

下载PDF
导出
摘要 目的研究胃癌患者组织环氧化酶2及血管内皮细胞增殖标志物表达的变化情况。方法将2016年2月至2017年11月的78例胃癌患者选为观察组,同时期的78例胃部良性疾病就诊患者选为对照组。比较两组的组织环氧化酶2及血管内皮细胞增殖标志物(CD105及CD31)的表达情况,并比较观察组中不同分化程度患者的表达情况。结果观察组的组织环氧化酶2及血管内皮细胞增殖标志物(CD105及CD31)的阳性表达率高于对照组,观察组中低分化患者的阳性表达率高于中分化及高分化者,中分化则高于高分化者,差异有统计学意义(P<0.05)。结论胃癌患者组织环氧化酶2及血管内皮细胞增殖标志物呈现高表达状态,且随分化程度有一定的反应意义,因此在胃癌患者中的检测价值较高。
作者 徐雪瑶
出处 《中国医药指南》 2019年第36期89-89,共1页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献39

  • 1Fonsatti E,Nicolay HJ,Altomonte M,et al.Targeting cancer vasculature via endoglin/CD105:a novel antibody-based diagnostic and therapeutic strategy in solid tumors[J].Cardiovasc Res,2010,86(1):12-19.
  • 2Otrock ZK,Mahfouz RA,Makarem JA,et al.Understanding the biology of angiogenesis:Review of the most important molecular mechanisms[J].Blood Cells Mol Dis,2007,39(2):212-220.
  • 3Pandya NM,Dhalla NS,Santani DD.Angiogenesis:a new target for future therapy[J].Vascul-Pharmacol,2006,44(5):265-274.
  • 4Bozas G,Terpos E,Gika D,et al.Prechemotherapy serum levels of CD105,transforming growth factor beta2,and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy[J].Int J Gynecol Cancer,2010,20(2):248-254.
  • 5Cimpean AM,Raica M,Suciu C.CD105/smooth muscle actin double immunostaining discriminate between immature and mature tumor blood vessels[J].Rom J Morphol Embryol,2007,48(1):41-45.
  • 6Zvrko E,Mikic A,Vuckovic L.CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma[J].Eur Arch Otorhinolaryngol,2009,266(12):1971-1976.
  • 7Minhajat R,Mori D,Yamasaki F,et al.Endoglin (CD105) expression in angiogenesis of colon cancer:analysis using tissue microarrays and comparison with other endothelial markers[J].Virchows Arch,2006,448(2):127-134.
  • 8Uneda S,Toi H,Tsujie T,et al.Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature[J].Int J Cancer,2009,125(6):1446-1453.
  • 9Lee SY,Hong YD,Felipe PM,et al.Radiolabeling of monoclonal anti-CD105 with (177)Lu for potential use in radioimmunotherapy[J].Appl Radiat Isot,2009,67(7-8):1366-1369.
  • 10Fujita K,Ewing CM,Chan DY,et al.Endoglin (CD105) as a urinary and serum marker of prostate cancer[J].Int J Cancer,2009,124(3):664-669.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部